ZNF518B

protein-coding

zinc finger protein 518B, the group of Zinc fingers C2H2-type

Gene summary

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jun 2026]

MANE transcript

NM_053042.3

Inheritance

—

ClinVar variants

U:175B:14

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.34

Max pathogenic AF

—

Genomic locus

chr4:10,439,880-10,457,426

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~17.5 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

schizophreniaNO_KNOWN

Inheritance Pattern: Unknown

Disease ID:MONDO:0005090

Submitter: Labcorp Genetics (formerly Invitae)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ZNF518B variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 181
not providedTotal: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_053042.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
clinvar
2
missense
174
clinvar
13
clinvar
187
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total00175140189
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 31 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_053042.3RefSeqNP_444270.21MANE Select
ENST00000326756.4EnsemblENSP00000317614.31MANE Select
NM_001375816.1RefSeqNP_001362745.11Standard
NM_001375817.1RefSeqNP_001362746.11Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • regulation of transcription by RNA polymerase II

Molecular Function

  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA binding
  • metal ion binding

Cellular Component

  • nucleus

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000326756
Coding exons
1
Length
17537
Individuals with no LoFs
125698
Homozygous LoFs
0
Heterozygous LoFs
49
Defined
125747
p
0.000195
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-1.926725461.230.00002937067
Missense (PolyPhen)151151.520.996581999
Synonymous-3.382702081.300.00001172098
Loss of Function3.311029.40.3400.00000144451

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000180.00018rare
Latino/Admixed American0.000200.00020rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish0.000140.00014rare
European (Non-Finnish)0.000200.00020rare
South Asian0.000360.00036rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: May be involved in transcriptional regulation.;

Recessive Scores

pRec
0.0837

Intolerance Scores

LoFtool
0.553
RVIS EVS
0.66
RVIS percentile EVS
84.2

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.0846

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.